RxDoctor Payments Data

William Coleman, MD

Procedural Dermatology · Metairie, LANPI 1861585283

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,725 of the $2,100 with a category attached, or 82.2%. AbbVie accounts for 94.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $1,782 and has fallen 94.6% since, to $96 in 2025.

$2,100in general payments, 2019–2025

Across 27 payments — averaging $77.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sanofi$53
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$28
  • Medtronic$26
$3,375,458in research payments, 2019–2025

Across 183 payments — averaging $18,445 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$2.8M
  • Merz North America, Inc.$408K
  • Endo Pharmaceuticals Inc.$117K
  • Bausch Health US, LLC$26K

What the payments were for

  • Consulting fees$1,72582%
  • Food & beverage$37518%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)22$1,993
Sanofi2$53
Ortho Dermatologics, A Division Of Bausch Health US, LLC2$28
Medtronic1$26

How this compares

Too few procedural dermatology providers in Louisianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$18,748
Medicare patients
48
Services billed
171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate19$410
Finasteride25$144
Minoxidil17$117

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →